IV Pulse Dexamethasone Plus [KL1] Topical Corticosteroids for Severe Pediatric Alopecia Areata
Researchers compared 1-day intravenous dexamethasone pulses with 3-day pulses in a small cohort of children and adolescents with severe AA.
Alopecia Areata
C-Reactive Protein Levels Potential Hematologic Marker of Severity in Alopecia Areata
Researchers believe their study to be among the first to show the relationship between the hematologic and inflammatory parameters of alopecia areata and disease severity.
Patients With Alopecia Areata at Increased Risk for Depression and Anxiety
Researchers completed a comprehensive meta-analysis examining existing literature to study the relationship between alopecia areata, anxiety, and depression.
Differences of Nonscarring Alopecia in Systemic Lupus Erythematosus
Investigators review the various clinical patterns and trichoscopic, histopathological, and direct immunofluorescence characteristics of nonscarring alopecia in patients with systemic lupus erythematosus and confirm its link to disease activity.
Mortality Associated With Self-Harm, Psychiatric Diseases Higher in Patients With Alopecia Areata
A number of risk factors contribute to the higher mortality rate found in patients with alopecia areata.
Cyclosporin Possibly Effective to Induce Hair Regrowth in Alopecia Areata
Cyclosporin monotherapy was moderately effective at inducing hair regrowth, but the overall response rate did not reach statistical significance.
Rapid Therapeutic Effect in Alopecia Areata Seen With JAK3, TYK2, and JAK1 Inhibitors
PF-06700841 and PF-06651600 were found to have an effect onset of 6 and 4 weeks, respectively in patients with moderate to severe alopecia areata.
Alopecia Areata: Clinical Characteristics of Those With and Without Poliosis
Poliosis may be induced among elderly persons with AA who have a poor melanocyte reservoir status.
Subcutaneous Dupilumab Initiates Hair Regrowth in Patient With Alopecia Totalis, Atopic Dermatitis
Dupilumab, commonly used for eczema, may be effective for hair regrowth in patients with alopecia totalis and atopic dermatitis.
Low-Dose Ruxolitinib May Promote Hair Regrowth in Severe Alopecia
Complete or near-complete hair regrowth occurred in 5 patients, with a 98% improvement in the Severity of Alopecia Tool score.
Next post in General Dermatology
